Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,773 signal articles · 68 in last 24h · 148,348 total before filter · latest 1h ago
68last 24h
974last 7d
109● bullish (7d)
123● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst10
✕ clear all filtersticker: TGTsentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How Big A Swing In eBay Stock Are You Actually Holding?
Trefis21h agoneutral
How Big A Swing In eBay Stock Are You Actually Holding?

eBay (EBAY) stock trades at about $113. It has returned 28.7% over the past year and sits about 5% below its 52-week high. The options market is pricing substantial movement ahead, with implied volatility pointing to a wide one-standard-deviation range between $79.44 and $160.45 over the next twelve months.

Target (TGT) Stock Fair Value Rises After Q2 Spurs Higher Analyst Targets
Simply Wall St.1d agoneutral
Target (TGT) Stock Fair Value Rises After Q2 Spurs Higher Analyst Targets

Target is back in focus after analysts raised their fair value estimate from about US$133.84 to roughly US$162.76, a move that aligns with a wave of higher price targets across Wall Street. This shift follows Q2 research that has become more constructive, with firms debating how much of Target's merchandising and traffic recovery is already reflected in the stock. Read on to see what is driving the changing story around Target and how to keep track of the next phase in this evolving...

Can Kroger Keep Its Earnings Promise With Sales This Weak?
Trefis1d agoneutral
Can Kroger Keep Its Earnings Promise With Sales This Weak?

Kroger (KR) has cut its 2026 same-store sales outlook and kept its 2026 profit outlook. If you own the stock, the easy comfort is that earnings held. The risk sits inside that comfort. The cost savings holding up profit are the same savings management plans to spend on lower shelf prices, and the stock is down 15% over the past six months.

Will Target’s (TGT) New Marketing Chief and Partner Push Quietly Redefine Its Competitive Moat?
Simply Wall St.3d agoneutral
Will Target’s (TGT) New Marketing Chief and Partner Push Quietly Redefine Its Competitive Moat?

In recent weeks, Target’s partners have announced a flurry of expansions into its ecosystem, including Amylu Foods’ projected 50% retail footprint growth by end-2026 driven by a major Target rollout, plus nationwide launches across Target Beauty Studio and new food, confectionery and wellness offerings in more than 600 stores and online. Target also hired former Hilton global CMO Mark Weinstein as chief marketing and guest experience officer, signaling a push to more tightly connect...

Jim Cramer Says “Target’s Doing Better than Walmart Right Now”
Insider Monkey3d agoneutral
Jim Cramer Says “Target’s Doing Better than Walmart Right Now”

Inquiring about Walmart Inc. (NASDAQ:WMT) on September 10, a caller asked if they should “keep it.” Mad Money host Jim Cramer replied: I got to tell you, this one is a short and long-term, okay? Short-term, I think I know what Walmart’s doing. I think that they’re letting their customers have a big break. They’re […]

Is eBay Stock Worth The Ride?
Trefis3d agoneutral
Is eBay Stock Worth The Ride?

eBay (EBAY) has gained 5.4% over the past five trading days while the S&P 500 fell 1.3%. A stock rising in a falling market pulls money in. Five days say nothing about what a holding does to your money over the years you would own it. eBay's longer-term record presents a more mixed risk-adjusted picture.

Attack of the Clones Speeds Up CVS Strategy
The Wall Street Journal4d agoneutral
Attack of the Clones Speeds Up CVS Strategy

“No, I don’t think so,” answered Joon Sung Park, co-founder and CEO at “digital twin” startup Simile, on the opening day of the Leadership Institute’s WSJ Technology Council Summit yesterday. Twins created with Simile are currently helping CVS Health make decisions more quickly and confidently, executives said as part of the same discussion. When the pharmacy and insurance company wanted to encourage adoption of lower-cost biologic drug alternatives, twins of the consumer pool suggested that people wanted to hear recommendations from their healthcare providers, said Tilak Mandadi, executive vice president of ventures and chief experience and technology officer at CVS Health.